Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Report Examines Programs That Would Give HIV-Positive People Access to New Drugs Before Final Federal Approval

June 22, 2007

"Rethinking the Approach to Expanded Access Programs," Forum for Collaborative HIV Research: The report says that reform of expanded access programs that allow HIV-positive people to take new drugs before final federal approval is needed. Although EAPs can be important to HIV-positive people who have developed resistance to currently available drugs, the system for providing access to experimental drugs is "fragmented and underfunded," according to the report. It adds that the system "discourages academic health centers and private physicians from participating." The report reviews the problems associated with the system and provides guidelines aimed at improving it, including a recommendation that pharmaceutical companies reimburse health care providers for EAP costs. "The goal of expanded access programs is to make promising drugs in the late stages of clinical trials available to patients who urgently need treatment and have exhausted all currently approved therapies," Ben Cheng, deputy director of the forum said, adding, "Unfortunately, the current mechanism for early access to these promising drugs serves neither patients, companies nor regulators" (Forum for Collaborative HIV Research release, 6/14).

Back to other news for June 2007


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More U.S. HIV Treatment Policy Analysis

Tools
 

Advertisement